In a research report published today, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on GW Pharmaceuticals (NASDAQ:GWPH) with a price target of $147, …
In a research report issued today, Piper Jaffray analyst Joshua Schimmer weighed in with his thoughts on Gilead Sciences (NASDAQ:GILD), following the news that Express Scripts (NASDAQ:ESRX) has …